JP2025506429A5 - - Google Patents

Info

Publication number
JP2025506429A5
JP2025506429A5 JP2024546276A JP2024546276A JP2025506429A5 JP 2025506429 A5 JP2025506429 A5 JP 2025506429A5 JP 2024546276 A JP2024546276 A JP 2024546276A JP 2024546276 A JP2024546276 A JP 2024546276A JP 2025506429 A5 JP2025506429 A5 JP 2025506429A5
Authority
JP
Japan
Prior art keywords
lipid
phospholipid
composition
lipids
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024546276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506429A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062063 external-priority patent/WO2023150757A1/en
Publication of JP2025506429A publication Critical patent/JP2025506429A/ja
Publication of JP2025506429A5 publication Critical patent/JP2025506429A5/ja
Pending legal-status Critical Current

Links

JP2024546276A 2022-02-07 2023-02-06 免疫原性mRNA送達ビヒクル Pending JP2025506429A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307578P 2022-02-07 2022-02-07
US63/307,578 2022-02-07
PCT/US2023/062063 WO2023150757A1 (en) 2022-02-07 2023-02-06 Immunogenic mrna delivery vehicles

Publications (2)

Publication Number Publication Date
JP2025506429A JP2025506429A (ja) 2025-03-11
JP2025506429A5 true JP2025506429A5 (enExample) 2026-02-12

Family

ID=85640795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546276A Pending JP2025506429A (ja) 2022-02-07 2023-02-06 免疫原性mRNA送達ビヒクル

Country Status (9)

Country Link
US (1) US20250134994A1 (enExample)
EP (1) EP4475824A1 (enExample)
JP (1) JP2025506429A (enExample)
CN (1) CN118843455A (enExample)
AU (1) AU2023216364A1 (enExample)
CA (1) CA3250781A1 (enExample)
IL (1) IL314720A (enExample)
TW (1) TW202345909A (enExample)
WO (1) WO2023150757A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118267481A (zh) * 2024-04-08 2024-07-02 浙江大学 一种环境适应性协同调控的mRNA纳米递送系统的构建与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101951933B1 (ko) * 2013-03-12 2019-02-25 주식회사 아리바이오 라이소포스파티딜콜린 또는 이의 유도체를 포함하는 지질나노물질 및 이의 제조방법
CN109692326A (zh) * 2017-10-23 2019-04-30 华中科技大学 一种蜂毒脂质纳米颗粒的应用
EP4228658A4 (en) * 2020-10-14 2025-02-19 George Mason Research Foundation, Inc. IONIZABLE LIPIDS AND METHODS FOR THE PRODUCTION AND USE THEREOF
WO2022221827A2 (en) * 2021-04-12 2022-10-20 Corner Therapeutics, Inc. Hyperactivators of mammalian dendritic cells

Similar Documents

Publication Publication Date Title
TWI386209B (zh) 前列腺素e1之乳化組成物
CN101043875B (zh) 糖皮质激素和糖皮质激素衍生物的脂质体组合物
JP2022530018A5 (enExample)
JP5981997B2 (ja) 薬理学的活性物質の徐放性脂質初期製剤およびこれを含む薬学的組成物
JP6392209B2 (ja) 粘液内層を通過する迅速な透過のための脂質ベース薬物キャリア
US6514523B1 (en) Carrier particles for drug delivery and process for preparation
US9452179B2 (en) Vesicular formulations
KR101476167B1 (ko) 약물 송달 제어용 경폐 투여 리포좀
CN104837482B (zh) 纳米颗粒制剂
Saraf et al. Sphingosomes a novel approach to vesicular drug delivery
JP2003530339A (ja) 寄生虫感染症の医療用途のための、ホスホリパーゼa2分解性脂質誘導体を含有する脂質ベースの薬物送達システム
JP2020532546A5 (enExample)
JP2025506429A5 (enExample)
JP2004505035A (ja) 荷電脂質組成物及びその使用方法
JP2003522193A (ja) ホスホリパーゼa2で分解可能な脂質誘導体を含有する脂質をベースとした薬物送達系、および治療におけるその使用
WO2019082139A1 (en) LIPOSOMAL FINGOLIMOD HYDROCHLORIDE INJECTION
CN1980671B (zh) 含有水难溶性喜树碱的脂质体制剂
JPWO2005021012A1 (ja) ゲムシタビン封入薬剤担体
JP2025506429A (ja) 免疫原性mRNA送達ビヒクル
JP2025505628A5 (enExample)
CA3258341A1 (en) Nucleic acids encoding a constituently active cyclic GMP-AMP synthase and associated immunogenic delivery vehicles
JP7463306B2 (ja) 関節内ステロイドの合併症を軽減する方法
US20250195461A1 (en) Fibrate Compositions for Treating Inflammation and Neuroinflammation
JP2911550B2 (ja) リポソーム製剤
Pylypenko “QUALITY BY DESIGN” IN LIPOSOMAL DRUGS CREATION